Covalon Announces Fourth Quarter and Year End Results for Fiscal 2023
2 min read
Author of the article:
Published Jan 26, 2024 • 10 minute read
Article content
- Reports 2023-Q4 revenue of $6.9 million – an increase of 28%, net loss from continuing operations of $2.9 million – an improvement of $1.2 million
- Reports full year 2023 revenue of $26.6 million – an increase of 47%, net loss from continuing operations of $4.5 million – an improvement of $5.2 million
MISSISSAUGA, Ontario — Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2023 fourth quarter and year end results for the period ended September 30, 2023.
Advertisement 2
Business Wire
2024-01-26 07:10:20
All news and articles are copyrighted to the respective authors and/or News Broadcasters. VIXC.Com is an independent Online News Aggregator
Read more from original source here…
